These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Single-dose tioconazole compared with 3-day clotrimazole treatment in vulvovaginal candidiasis. Stein GE, Gurwith D, Mummaw N, Gurwith M. Antimicrob Agents Chemother; 1986 Jun; 29(6):969-71. PubMed ID: 3524439 [Abstract] [Full Text] [Related]
28. Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis. Smith EB, Wiss K, Hanifin JM, Jordon RE, Rapini RP, Lasser AE, Kirschenbaum MB, Millikan LE, Parish LC, Rapaport MJ. J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1116-7. PubMed ID: 2370340 [No Abstract] [Full Text] [Related]
29. Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis. Droegemueller W, Adamson DG, Brown D, Cibley L, Fleury F, LePage ME, Henzl MR. Obstet Gynecol; 1984 Oct; 64(4):530-4. PubMed ID: 6384848 [Abstract] [Full Text] [Related]
30. A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections. del Palacio A, Ortiz FJ, Pérez A, Pazos C, Garau M, Font E. Mycoses; 2001 Oct; 44(5):173-80. PubMed ID: 11486455 [Abstract] [Full Text] [Related]
31. Bifonazole--a synopsis of clinical trials worldwide. Status and outlook. Stettendorf S. Dermatologica; 1984 Oct; 169 Suppl 1():69-76. PubMed ID: 6241160 [Abstract] [Full Text] [Related]
32. Treatment of chronic mucocutaneous candidiasis of children (Candida Granuloma) with Clotrimazole. Meinhof W, Günther D. Arch Dermatol Forsch; 1972 Oct; 242(3):293-308. PubMed ID: 4337938 [No Abstract] [Full Text] [Related]
33. Clotrimazole (Lotrimin)--a new topical antifungal drug. Med Lett Drugs Ther; 1975 Sep 12; 17(19):77-8. PubMed ID: 1177811 [No Abstract] [Full Text] [Related]
34. Superficial mycoses: treatment with a new, broad-spectrum antifungal agent: 1% clotrimazole solution. Zaias N, Battistini F. Arch Dermatol; 1977 Mar 12; 113(3):307-8. PubMed ID: 320940 [Abstract] [Full Text] [Related]
35. Chronic mucocutaneous candidiasis. Successful treatment with intermittent oral doses of clotrimazole. Rockoff AS. Arch Dermatol; 1979 Mar 12; 115(3):322-3. PubMed ID: 434848 [Abstract] [Full Text] [Related]
36. Impact of Process Parameters on Particle Size Involved in Media Milling Technique Used for Preparing Clotrimazole Nanocrystals for the Management of Cutaneous Candidiasis. Patel V, Sharma OP, Mehta TA. AAPS PharmSciTech; 2019 Apr 26; 20(5):175. PubMed ID: 31028492 [Abstract] [Full Text] [Related]
37. Diffuse chronic muco-cutaneous candidiasis: report of two patients treated with topical clotrimazole and replacement of nutritional deficiencies. Higgs JM, Wells RS. Guys Hosp Rep; 1973 Apr 26; 122(1-2):135-53. PubMed ID: 4804324 [No Abstract] [Full Text] [Related]
38. Vulvovaginal candidosis: comparison of 3-day treatment with 2% butoconazole nitrate cream and 6-day treatment with 1% clotrimazole cream. Hajman AJ. J Int Med Res; 1988 Apr 26; 16(5):367-75. PubMed ID: 3197914 [Abstract] [Full Text] [Related]
39. Vulvovaginal candidiasis treated with clotrimazole cream in seven days compared with fourteen-day treatment with miconazole cream. Robertson WH. Am J Obstet Gynecol; 1978 Oct 01; 132(3):321-3. PubMed ID: 360842 [Abstract] [Full Text] [Related]